ABSTRACT. To determine significant thresholds obtained by bronchial challenge tests in children for assessment of bronchial reactivity, changes of respiratory resistance (Ri.1) induced by inhaled carbachol were evaluated in 20 asthmatic children (10 boys and 10 girls, mean age 9.1 f 2.8 y, range 5 to 15 y) and 20 healthy control children (10 boys and 10 girls, mean age 12.1 2 2.6 y, range 8 to 16 y). Baseline lung function was assessed by whole body plethysmography. The carbachol challenge test was performed by the interruption technique. The objectives were to search for the most predictable provocation dose (PD) according to statistical and practical considerations. The statistical argument is given by the condition that the target PD must definitivelv be out of the measurement error of baseline values. ~r o m the practical point of view, the object is to provoke the subjects the least amount possible. As thresholds of bronchial reactivity, the provocation doses inducing a 50%, 6570,7576, or 100% increase in baseline Rint (PDw, PD65, PD75, PDIW) were computed by a 4th power polynomial function analysis including data points of the entire dose-response curve. In comparison, a new threshold, the "variance based" provocation dose (PDVb), was defined as threshold to be definitively above the range of the baseline Rint variation before initiating challenge [PD,b > mean + 2 SD range of Rint(O)]. Although the PDw, PD65, PD75, and PDIW can be adequately computed by the 4th power function from the whole dose-response curve, comparison between the different provocation thresholds revealed that PDVb gives the best values to differentiate between healthy and asthmatic children (p < 0.002). Best cumulative sensitivity and specificity were obtained for PDVb and even at a lower provocation level (95% true-negatives at 300 pg; 95% true-positives within the range up to 780 pg of carbachol), whereas these criteria for PDw to PDlW are only reached at much higher doses. Therefore, PDVb features a mode to determine bronchial reactivity with improved sensitivity and specificity at lowest provocation dose levels. Other advantages are a shorter duration of testing, less occurrence of symptoms and a simpler mathematical approach. (Pediatr Res 34: 478-484, 1993) Abbreviations BR, bronchial reactivity FEVI, forced expiratory volume in 1 s MEFW, maximal expiratory flow at 50% of vital capacity PDw/6s/7s/loo, provocation dose (pg carbachol) increasing Rint from baseline (100%) to 150, 165, 175, or 200% 
PDVh variance-based provocation dose; threshold significantly above baseline values [RinI(O)l R. , , airway resistance, plethysmographically determined Rinl, respiratory resistance, measured by the interruption method Rint(0), baseline respiratory resistance, measured by the interruption method s, sensitivity J; specificity TGV, thoracic gas volume (end-expiratory resting level, plethysmographically determined)
The procedure of inhalative bronchial challenge tests and its accuracy to assess the degree of BR in a healthy and asthmatic adult population is well standardized and documented (1-6). It has also become a valuable test in children (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Although the bronchoconstrictor responses to physical or natural challenges of exercise. hyperventilation of cold. dry air. and hypo-or hyperosmolar stimuli seem to be more sensitive for asthma but less specific in detecting nonspecific reactivity in nonasthmatic subjects (2 1. 22) . the most common way to detect BR in children is the inhalation of an agent such as histamine or acetylcholine derivatives that induce bronchoconstriction. However, despite the usefulness of a pharmacologic test to define the clinical conditions of asthma (6) . concluding that a provocation causing a 20% fall in FEV, supports the clinical diagnosis of asthma currently present in children, some technical conditions should be observed. Forced breathing maneuvers are highly cooperation dependent, which may cause problems in young children. In addition, such test procedures do not allow the reaction of the bronchial system to be followed breath by breath and thus do not fulfill the requirements of safety for routine use in children. Finally, the observation that children have more responsive airways than adults (lo. I I ) has to be taken into account. There exists no satisfying standardization of the most suitable test procedure to ensure safety, to have the least dependency on the child's cooperation, and to offer more convincing data for accurate test ,f and s.
This article reports on a new. safe technique to follow bronchoconstrictor response to carbachol chloride, delivered in standardized quantities, measuring R,,, changes breath by breath. For the analysis of the dose-response curve, different curve-fitting models were used to compute the cumulative doses of carbachol that had been inhaled during subsequent provocation levels in each patient. According to the increase of RBnI (150%. 165%. 175%. and 200% of the baseline value) four response levels (PDSo, PDb5. PDTS. and PDloo) were empirically selected and defined. The question was posed whether such a PD in its standard form represents significant provocation thresholds and whether another analytic treatment of the dose-response curve 78 would better reflect BR in healthy and asthmatic children, taking into account practicability, safety, and accuracy of the test for the pediatric population.
MATERIALS AND METHODS
Heulrh~* suhjc~cts. Twenty healthy children (10 boys and 10 girls, mean age 12.1 f 2.6 y, range 8 to 16 y) investigated for other purposes ( 18) represent the control subjects. Standardized case histories and physical examinations were taken by trained pediatricians and, in case of doubts. histories were verified with the family doctor. The criteria for inclusion into the study were that the child was healthy, especially free from respiratory symptoms, and showed no signs of viral infections or vaccinations during the last 6 wk before the test. Atopic diseases were excluded by determination of normal serum IgE (Pharmacia) and absence of positive radioallergosorbent tests (Phadiatop Kabi Pharmacia. Stockholm. Sweden) for grass pollen. house dust mites, and animals.
Asthmatic childrm. Twenty asthmatic children with exogenous allergic asthma (10 boys and 10 girls, mean age 9.1 f 2.8 y. range 5 to 15 y) seen at the Paediatric Pulmonary Out-patient Clinic of the University Children's Hospital in Berne, Switzerland, were randomly selected as study patients. In each patient. asthma was diagnosed by a history of recurrent attacks with wheezing, elevated IgE levels (paper radioimmunosorbent test), positive specific IgE (radioallergosorbent) for one or more allergens, and the documentation of airway obstruction (Raw, FEVl. and MEFso), which was reversible with sympathomimetics (2. 4-6). At the time of testing, the patients were in a symptom-free interval (no signs of asthma clinically detectable) and the last acute asthma episode was at least 2 wk before the examination.
Bronchodilator treatment was withheld 12 h before. inhalative steroids or disodium cromoglycate 24 h before the test. None of the patients were on xanthine treatment, systemic steroids. or oral P-2-agonists. All parents gave informed consent for the examinations and investigations, and the study was approved by the local ethical committee.
Lungfirnction tests. After the medical interview and a physical examination. pulmonary function tests were performed. The functional abnormalities were evaluated by whole-body plethysmography (16. 23, 24) , using an air conditioned, constant volume, variable pressure whole-body plethysmograph (Jaeger, Wiirzburg, Germany). TGV at resting level was taken as an estimate of the degree of pulmonary hyperinflation, and R,, as an estimate of the degree of bronchial obstruction. The Raw was determined at half inspiratory flow, the subject rebreathing from a Douglas bag under body temperature pressure saturated conditions. For TGV, static respiratory efforts against the shutter were performed at low frequency and TGV was calculated by the Boyl's law technique. TGV values were corrected for resting expiratory levels of the spirogram. The instrumental dead space of the mouthpiece and the estimated stomach gas volume were subtracted. Based on TGV at end-expiratory resting level, static lung volumes, the total lung capacity, the inspiratory vital capacity, and the residual volume were obtained. R,, was measured during calm breathing (no panting) of air from a Douglas bag. Row-volume curves gave the FEVI and the MEFso. Lung function data were expressed as a percentage of predicted values (25) . Bronchial challenge te.st. Inhalative provocation tests were performed with the Bronchoscreen (Jaeger), a computerized apparatus with a combined nebulizer-shutter head measuring with each breath changes in the Rinl. During calm breathing, this technique, originally developed by van Neergaard and W i n (26) and further improved by Veuilleumier (27) and others (28-3 I), measures R,,, after interruption of the airflow during 100 ms. from the "opening limb" of the interruption curve (29) , during each expiration. RtnI was determined using the formula Rint = (Pa~,/Pa, -I)R,,r, and the pressure in the alveolar compartment (Palv) was obtained indirectly by measuring the mouth pressure after closing the shutter. Pa, was the pressure measured during free flow at pressure equilibrium (28) . Rrer was a constant known serial resistance. With the subject seated, noseclip in place. the subject breathes air-conditioned ambient air to grow accustomed to the apparatus. Baseline measurements of R8nl(0) were performed by inhaling I0 to 20 breaths of physiologic NaCl solution (0.9%) from the built-in dosimeter. Carbachol chloride in saline buffered to pH 7.0 with sodium bicarbonate (Merck Inc., Darmstadt, Germany) was used in a low concentration solution of 1.25 mg/mL during the first I0 breaths. then in a higher concentration of 2.5 mg/mL until the end of the test procedure. This protocol was used for safety reasons to immediately detect children reacting to very low doses of carbachol. Generation time for aerosolization was 0.5 s. Multiple nebulizer output measurements revealed a mean output of 44.1 (SD 5.5) mg of solution per 10 breaths. and 23.1 (SD 1.7) mg per five breaths. Mean values of R,,, from five breathing cycles were calculated in relation to the cumulative dose at each level of carbachol. Special care was taken to increase the dose gradually, to achieve progressive small changes in R,.,. Using this procedure. a doseresponse curve was obtained and the provocation procedure was terminated when an increase of RtnI(O) to 185% was reached. Thereafter, inhalation was switched to a bronchodilator. The analytical approach to assess BR in healthy and asthmatic children from the provocation dose-response curves consisted in the computation of the provocation dose at 50%, 65%. 75%. and 100% increase of R,,,(O) (PDro. PDh5. PD75, and PDltx,).
Fitting modc.1. Starting at R,,,(O). the data were calculated as percent change from the postsaline value of R,,, against the cumulative dose of carbachol (Fig. I) . From previous experiences, the best fit of the dose-response curve was found by a 4th power function using the more general function derived from 
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based on the statistical consideration that a bronchial challenge test has be considered positive when R,,, significantly increases in relation to R,,,(O), the so-called "variance-based" provocation dose (PDVb) was defined. PDVh represents the threshold where R,., is significantly higher than the individual mean +2 SD of a particular subject at baseline. The validity of these computed provocation thresholds was double-checked by a two-tailed t test looking at the significance of the distribution of R,,, measurements on the different provocation levels in relation to the variation of Rint(0) data before the challenge test (Fig. 1) . By double-checking the provocation thresholds achieved stepwise using a t test, the changing variance and thus distribution of data points of each provocation level with respect to that at baseline are taken into account.
Statistical methods. Data were analyzed on a Macintosh computer with the statistical package SYSTAT 5.2. Relationships were explored using the x ' analysis of contingency tables, the Kruskal Wallis test for nonparametric variables, and multiple linear regression analysis. s is defined as the capacity of a test to positively identify those persons with the disease, and,f is defined as the capacity of a test to exclude as healthy those subjects who do not have the disease. Therefore, s was calculated as the ratio of the true-positive to the sum of the true-positive plus falsenegatives for the asthmatic population and f a s the ratio of the true-negatives and the sum of the true-negatives plus falsepositives in the healthy population.
RESULTS
Age, sex, and R,,,(O) of the 20 healthy and 20 asthmatic children are summarized in Table 1 . Baseline values of lung function measured in the asthmatic children before the challenge tests are given in Table 2 . Both collectives of randomly selected individuals reflect weighed means of corresponding populations. Seven asthmatic children showed lung function within the range of normal, whereas three presented with pulmonary hyperinflation (TGV > 130% of predicted value). 10 with bronchial obstruction of more central airways (R,, > 130% of predicted value), and nine with obstruction of more peripheral airways (MEF50 < 80% of predicted value), seven of them showing combined functional abnormalities. In addition, the individual values for PDVh and PDSo-PDIW are given (Table 1) . Whereas for PD,b all doses fell within the range of measured values (to 1200 pg of carbachol) in healthy and asthmatic subjects, an increasing number of subjects (two of 20 to 12 of 20 depending on threshold and/or collective concerned) showed values higher than 1200 pg of carbachol and thus would require extrapolation data.
In Figure 2 , the five thresholds PD,h, PDso, P D 6~, PD75, and PDlm are given. All PD calculated on the basis of the 4th power model showed wide variations, especially in healthy children. Therefore, in comparing data distribution according to Kruskal Wallis, no systematic difference between healthy and asthmatic children could be found. In contrast, PDVh, having for both healthy and asthmatic children a much lower mean than PDSo (656.8 & 292.7 pg of carbachol for healthy children; 376.5 + 265.2 pg of carbachol in asthmatics), showed less variation and therefore differentiates significantly between health and disease ( p < 0.002). Table 3 shows for each of the four computed PD (PD50. PD65. P D 7~, and PDlm) the proportion of threshold values that were higher than the mean Ri,,(O) +2 SD; this was taken as a measure of the accuracy of the PD. Although in asthmatics 100% accuracy can be achieved for PD65. P D 7~, and PDlw, in healthy subjects even the PDlm reached only 95% accuracy. By definition, the accuracy of PDVb is 100%. The discrepancy between both methods is obviously caused by the fact that the method of assessing PD,b takes full account of the baseline variability. In contrast, the other PD (PDso. PDhs. P D 7~, and PDIw) can give spurious values when variability is proportionally large, an event most likely to occur if R,,,(O) is low, or when very hyperreactive subjects (steep exponential dose-response curves) are tested.
In Figure 3 ,Jand s for all five PD are synoptically presented.
It can be seen that J and s for PD,h both are the most left positioned (lower dose levels). In addition, the 95% true-negative level for the,fof PDVh is reached already at 300 pg of carbachol and the 95% true-positive level of s of PDVh is up to 780 pg of carbachol, whereas these criteria for PDSo to PDlm are at much higher provocation doses. Therefore, f and s for PDVh are substantially better than for PDso. PDh5. PD7,, and PDlw. One analytic mathematical approach to establish suitability of a test is to depict the crossing point of the declining.fcurve with the increasing s curve of cumulative percent response (Fig. 3, middle) . It can be shown that the crossing point for the PDVh is already reached at 480 pg of carbachol giving an equalized,fand s of 70%. Therefore, PDVh features a mode to determine BR with improved,fand s at the lowest provocation dose levels.
DISCUSSION
The objectives of the present study were first to search for a convenient fitting model for dose-response curves of inhalative bronchial challenge tests to obtain accurate provocation thresholds in children. Second, this study intended to identify the best predictable target PD within a lower and upper limit of the dose scale. The former is given by the statistical argument that the target PD must definitively be out of the measurement error of baseline values, and the latter is given by the practical aim to minimize induced airway obstruction. This allows comparison of how well the different provocation thresholds differentiate between health and disease. The question was asked whether an alternative simple calculation of a significant PD would not result in a test procedure that is free from a complex mathematical model. can be applied on-line. and shortens the duration of the test. In this context, the PD,h was elaborated. It is defined as the dose corresponding to the first significant increase of flow resistance in relation to the variability of baseline resistance.
It was not the aim of this study to find a mathematical expression that fits all the data points perfectly, or to predict whether the curves are exponential or sigmoid in shape, but to find a mathematical expression that would allow simple computation of different provocation thresholds. Another purpose was to explore differences in constants between normal and asthmatic children; therefore, the mathematical model was chosen for both subject groups. In healthy children, it seems likely that the data points describe a sigmoid function. In asthmatic children, this depends on whether the test procedure was discontinued because of a dramatic exponential increase in airflow resistance. The constants obtained in a previous study (33, 34) have not shown any significance in clinical terms, either for P, indicating the position of the curve, or for y as index of the slope of the dose-response curve.
The validity of our computed curve fits was analyzed by looking at the significance of the distribution of R,,, measurements for the different provocation levels in relation to the variation of R,.,(O) data before the challenge test. As defined in the present study. PD,b is the provocative dose at which respiratory resistance is statistically significantly increased, i.e. outside the range of baseline values (mean + 2 SD). It is of interest to have the test standardized to achieve a provocation level that is sufficiently high [out of the 2 SD range of variability of Rint(0)], but not so high that the patient feels discomfort. Apart from biologic considerations, statistical arguments have an important role to play in establishing a provocation threshold. Especially in children, lung function parameters vary considerably, and with respect to the dose-response curve during bronchial provocation, it must be assumed that variation predominantly in the exponential part of the curve is substantial. By that it can be explained that accuracy. s, and .fare better for PD,h. While calculating PD,h, a direct comparison between the range of individual single This approach is independent from any assumptions about the underlying shape of the dose-response curve and therefore generally applicable. By taking PDVh as target PD, better s andJare achieved, even at lower dose of the challenging agent. Another desirable feature of any analytical procedure is that it helps limit the test time to a minimum while producing accurate results. We would speculate that, based on the data obtained by the new calculation of PDVb, discrimination between healthy and asthmatic children could be improved. Limits ofmerhods. The interruption technique to measure R,,, as an estimate of respiratory resistance has not been widely used, partly because the equipment is expensive and partly because of theoretical reservations regarding the validity of the method. Recent theoretical analyses by Bates et a/. (35, 36) suggest that the method is essentially valid, although upper airway compliance may cause R,,, to underestimate the true value of Raw. Upper airway compliance can be minimized by supporting the cheeks and pharynx. Experimental work in dogs by Bates el a/. (37) shows that in open-chested dogs R,,, closely approximates Raw even in the presence of parallel heterogeneity. In closedchested dogs. R,., is strongly correlated with airway resistance even in the presence of bronchoconstriction but includes a contribution from the chest wall and therefore tends to exceed Raw (38. 39). More recently, close correlation was found comparing R,., and Raw in 43 adult patients (40) . Changes in R,,, after use of a bronchodilator were similar to those in R,,. and the comparison of the average percentage change was within 2%. Acceptability was also checked in 10 3-y-old asthmatics showing an increase of R,., after methacholine and a decrease after salbutamol (39) . In view of this recent theoretical and practical work and the advantages of the method. this technique provides an instantaneous. breath by breath measurement of respiratory resistance that can be successfully used in a pediatric population.
The form of the algorithm used to extrapolate mouth pressure to obtain R,,, requires further evaluation. Bates c't a/. have suggested a more sophisticated exponential procedure (36) . In cases where pulmonary hyperinflation is present and thus the site of resistance lies upstream (on the alveolar side) of a compliant compartment, true airway resistance is underestimated (31) . Therefore, we already proposed to apply an entire resistance-capacitance-inertance model to obtain a more reliable estimation of R,., (3 I). There is increasing concern that the end-expiratory resting level may change during the provocation procedure. In consequence, the dose-response curve of a bronchial challenge representing changes in airway mechanics may be significantly influenced by changes in volume history. Because of the difficult technical approach, we have not been able to verify this point in the present study. However, in another study we have been able to demonstrate the influence of the kind of functional abnormality (pulmonary hyperinflation, bronchial obstruction, or mixed type) as a confounding factor for the detection of bronchial hyperreactivity in asthmatic children (33) . In addition, potential changes in end-expiratory resting level during a bronchial challenge may influence the exact detection of the degree of bronchial obstruction.
Reprodzrcihiliry und ethical considerations. Carbachol is highly cumulative in its action. The pharmacologic property precludes repeating the test at short intervals, so that the reproducibility of the PDVh can be established in stable asthmatics in whom measurements are repeated on different days: this did not form part of the protocol and needs to be established in future studies. In view of the cumulative effects, we also recommend that the test be terminated by administration of a 0-2-agonist, so that respiratory resistance is restored at a lower level. It follows that, for a repetition of a bronchial challenge, not only the previous challenging agent but in parallel also the interaction of the P-2-stimulator have to be considered. Each second test will unavoidably be influenced by the preceding test. When the second test is postponed until the next day. the patient, especially the asthmatic child. will naturally be in a different condition with respect to lung function. Therefore, it is extremely difficult to achieve identical baseline conditions. In consequence, it was deemed unethical to perform such repeated tests in children. Moreover, it is of utmost interest and of an urgent need to have clear recommendations for such research in pediatrics.
Practical u s p~~t s :
alternative techniqzr~>.~. In an older age range of children, measurements using forced breathing maneuvers and taking the FEVI as a target parameter to estimate the testinduced bronchial obstruction can be considered the gold standard. It was not a formed part of the present study and because of the age range of the study subjects (5-1 5 y) it was not possible to compare the interruption technique with the technique using forced breathing maneuvers. However, such comparison was made in another group of older asthmatic children comparing Ri., with FEVI and MEFso at different provocation levels (unpublished data). In only 56% did R,,, behave similarly to FEVI. The correlation largely depends on whether asthmatic children with pulmonary hyperinflation, bronchial obstruction, or both were investigated. The only other technique that does not involve a high degree of active cooperation is the forced oscillation technique (41. 42) . However, this technique involves the patient maintaining a patent upper airway for several seconds. This was particularly difficult for young children. R,,, is measured during spontaneous airflow when momentary closure of the glottis does not occur. The advantages of calculating PDVh and its application to assessing BR are safety and accuracy. For practical purposes, there is no need to have a sophisticated curve-fitting model. which is time-consuming and does not reflect a biologic model applicable to both patients and healthy subjects. In addition, extrapolation must be avoided. For the present study, the number of PD that has to be judged "inaccurately assessed" can be obtained from Table 1 and Figure 2 (PDx > 1200 pg of carbachol). The new technique features the additional advantage that the test procedure can be consistently shortened in time. because a much lower dose needs to be administered for even better S a n d s. This latter point is also an argument for safety.
We do not yet have sufficient experience with applying this technique to children aged I to 5 y, and so far, comparison with the technique previously worked out by Godfrey and coworkers (43-45) cannot be made. By this latter technique, lung sounds are recorded at the tracheal level for 1 min after nebulization of a bronchoconstricting drug and the concentration causing "wheeze" is taken as the target parameter. The validity of our test procedure and calculation of PDVh will be evaluated in much larger collectives, using the present algorhithm for measurements of respiratory system resistance. 
